Detalhe da pesquisa
1.
Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.
Proc Natl Acad Sci U S A
; 110(24): E2239-48, 2013 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23729813
2.
Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
J Pharmacol Exp Ther
; 342(3): 642-53, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22637724